There is also a general reluctance to report unfavorable drug effects. Physicians may feel guilty and fear litigation, drug companies worry about the threat to corporate profits and regulatory agencies must face the question Why was the drug approved in the first place?

Above all, the success of any comprehensive effort to improve drug safety hinges upon establishing an independent office of drug safety to advocate, coordinate, and provide direction to the regulatory agenda. Such an office exists in the United Kingdom.

Proper and complete documentation of harmful drug effects is difficult. Spontaneous reporting rates to regulatory agencies are low approximately 1 and ongoing monitoring is passive in many countries.

4. Recommends that Member States develop or further adapt, where necessary, their regulatory and operational control procedures to counter the diversion of chemical substances into illicit drug production or manufacture, and encourages authorities to initiate or further strengthen coordination and cooperation between all regulatory and enforcement services involved in precursor control

Second, improvement of drug development requires more transparency from the regulatory bodies. At present, a new drug s producer prepares the entire dossier presented to the regulatory authority for approval in the interests of the public, at least one of the clinical trials should be carried out by an independent non profit organization.

Regulatory issues

Regulatory action

Other regulatory controls

Fourth, regulatory structures will need to be rebuilt, and this will require a global effort. Absent international coordination, the opportunities for destructive regulatory competition will defeat regulatory reform.

China Insurance Regulatory Commission

China Securities Regulatory Commission

Legal and regulatory environment3

At the same time, governments will have to implement policies aimed at guiding investment toward specific diseases. For example, increased NIH funding, extended market exclusivity, and relaxed regulatory hurdles in the US resulted in a renaissance in antibiotic drug development.

(c) Feedback from assisted States attributes, in whole or in part, significant regulatory, prosecution, sentencing, asset forfeiture and drug abuse reduction outcomes to the use of legislation development, legal advice, products or other expertise delivered under the legal advisory programme

The Harm of Regulatory Disharmony

Franchising poses particular regulatory challenges.

(a) The Division for Policy Analysis and Public Affairs, whose aim is to increase knowledge and understanding of drug and crime issues and to expand the evidence base for policymaking and operational decisions

The treaty and legal affairs pillar of the Division is concerned with the promotion and implementation of United Nations legal instruments in the areas of drug abuse control, transnational organized crime and corruption.

The Office will continue to support implementation of the international drug control treaties by providing scientific advice and expertise also to national regulatory and competent authorities, the Commission on Narcotic Drugs, the International Narcotics Control Board and other relevant regional and international bodies.

In the sixth preambular paragraph, the words national and legal regulatory infrastructure should be replaced by national, legal and regulatory infrastructure .

For example, American, European, Japanese, and other drug regulators have developed guidelines, through the International Conference on Harmonization, that take advantage of their collective expertise. Countries such as South Korea and Singapore are drawing on these guidelines to flesh out their own regulatory systems.

China Securities Regulatory Commission 2008 04 16

Policy, Regulatory Frameworks and Equitable Benefit Sharing

First, there are legislative and regulatory measures.

(a) In the sixth preambular paragraph, the words national and legal regulatory infrastructure were replaced by the words national legal and regulatory infrastructure

China s decision to execute the head of its drug regulatory agency has rekindled international debate about capital punishment. It is an age old question, one that harks back to Plato, who in his Laws saw the need to punish by death those who commit egregious crimes.

Emphasizing the primary importance of international cooperation in combating drug trafficking and drug abuse,

International drug control

International drug control.

International drug control

Intravenous drug users

Drug demand reduction

Drug demand reduction

International drug control

Female drug addicts

International drug control.

It must be recognized that regulatory reform entails adjustment costs and necessitates regulatory capacity and institution building, technical assistance and capacity building in this regard.

And Tamiflu. You've probably heard of this drug, made by Hoffmann La Roche, patented drug.

As developing countries upgrade their regulatory systems, they should focus on closing legal gaps that put consumers at risk and undermine market credibility. In China, for example, the manufacturers of pharmaceutical ingredients can dodge drug regulation by claiming that their products will be used for non medical purposes.

And it has no rules to its regulatory system.

Illicit drug trends were to some extent determined by supply and demand, but drug cultivation was also about poverty, just as drug abuse was also about HIV AIDS.

The international drug control treaties provide the framework for international cooperation in countering the drug problem.

National drug control strategies

dopewars drug dealing game

Afghanistan s Drug Friendly Environment